Victory Capital Management Inc Poly Pid Ltd. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.66 - $38.7 $11,820 - $693,117	17,910 New	17,910 $12,000
Q4 2021 Feb 07, 2022	SELL	$5.52 - $8.42 $87,536 - $133,524	-15,858 Reduced 14.21%	95,759 $550,000
Q2 2021 Aug 03, 2021	SELL	$8.4 - $9.99 $46,922 - $55,804	-5,586 Reduced 4.77%	111,617 $1.01 Million
Q4 2020 Feb 01, 2021	SELL	$8.89 - $13.5 $19,424 - $29,497	-2,185 Reduced 1.83%	117,203 $1.16 Million
Q3 2020 Nov 09, 2020	SELL	$11.0 - $17.33 $556,732 - $877,105	-50,612 Reduced 29.77%	119,388 $1.31 Million
Q2 2020 Aug 07, 2020	BUY	$18.03 - $19.0 $3.07 Million - $3.23 Million	170,000 New	170,000 $3.07 Million

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.